Adjuvant erlotinib versus placebo in patients with stage IB-IIIA non-small-cell lung cancer (RADIANT): a randomized, double-blind, phase III trial - Kelly, K; Altorki, N K; Eberhardt, W E (J Clin Oncol, 2015)